Canton Strategic sells Gravitas Life Sciences to Gravitas Collective Corp
CNTN•Canton Strategic sells biotech R&D unit
Canton Strategic Holdings sold its biotech R&D unit, Gravitas Life Sciences, to Gravitas Collective.
The deal closed July 17, 2026.
Divestment sharpens focus on Canton Network strategy
The divestment sharpens focus on the Canton Network strategy to digitize traditional financial markets.
The shift follows progress in the operating business, including a locking service launched in June 2026.
